These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10941600)

  • 21. Apolipoproteins A1 and B levels and serum cholinesterase activity in hyperlipidemic subjects.
    Olinic D; Stoia M; Marian I; Trif I; Cucuianu M
    Rom J Intern Med; 1999; 37(1):71-9. PubMed ID: 15523947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome.
    Paragh G; Seres I; Harangi M; Erdei A; Audikovszky M; Debreczeni L; Kovácsay A; Illyés L; Pados G
    Br J Clin Pharmacol; 2006 Jun; 61(6):694-701. PubMed ID: 16722831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE; Barrett PH; Demant T; Parhofer KG
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term hypolipidemic treatment of mixed hyperlipidemia with a combination of statins and fibrates].
    Zeman M; Zák A; Vecka M; Romaniv S
    Cas Lek Cesk; 2003 Aug; 142(8):500-4. PubMed ID: 14626567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Etophylline clofibrate in the treatment of familial combined hyperlipoproteinemia].
    Raslová K; Hucková M
    Vnitr Lek; 1995 Apr; 41(4):240-2. PubMed ID: 7762188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
    Yanni AE; Perrea DN; Yatzidis HA
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
    Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
    Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention/reversal of choline deficiency-induced steatohepatitis by a peroxisome proliferator-activated receptor alpha ligand in rats.
    Rao MS; Papreddy K; Musunuri S; Okonkwo A
    In Vivo; 2002; 16(2):145-52. PubMed ID: 12073774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ciprofibrate in the treatment of combined hyperlipoproteinemia. Results in more than 600 patients from 23 centers in the Czech Republic].
    Ceska R; Kvasnicka T; Haas T; Soska V; Vaverková H
    Vnitr Lek; 2000 Mar; 46(3):157-60. PubMed ID: 11048518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The abnormal changes of apolipoprotein(s) in patients with type 2 diabetes mellitus].
    Ren Y; Tian H; Liu B; Liang J; Zhang X; Yao J; Xu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):48-51, 69. PubMed ID: 12733353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Separation of lipoproteins as a function of their apolipoprotein composition. Clinical applications].
    Fruchart JC
    Ann Biol Clin (Paris); 1986; 44(2):116-21. PubMed ID: 3092704
    [No Abstract]   [Full Text] [Related]  

  • 32. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III.
    Dallinga-Thie GM; Bu XD; van Linde-Sibenius Trip M; Rotter JI; Lusis AJ; de Bruin TW
    J Lipid Res; 1996 Jan; 37(1):136-47. PubMed ID: 8820109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia.
    Hsu HC; Lee YT; Yeh HT; Chen MF
    J Lab Clin Med; 2001 Jun; 137(6):414-21. PubMed ID: 11385362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in serum apolipoprotein and lipoprotein profile after alcohol withdrawal: effect of apolipoprotein E polymorphism.
    Gueguen S; Herbeth B; Pirollet P; Paille F; Siest G; Visvikis S
    Alcohol Clin Exp Res; 2002 Apr; 26(4):501-8. PubMed ID: 11981126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.
    Duez H; Lefebvre B; Poulain P; Torra IP; Percevault F; Luc G; Peters JM; Gonzalez FJ; Gineste R; Helleboid S; Dzavik V; Fruchart JC; Fiévet C; Lefebvre P; Staels B
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):585-91. PubMed ID: 15618549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia].
    Naruszewicz M; Nowicka G; Szostak WB; Kłosiewicz-Latoszek L
    Kardiol Pol; 1982; 25(7-8):527-31. PubMed ID: 7169740
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy and safety of a potent and selective peroxisome proliferator activated receptor alpha agonist in subjects with dyslipidemia and type 2 diabetes mellitus.
    Terra SG; Francone OL; Contant CF; Gao X; Lewin AJ; Nguyen TT
    Am J Cardiol; 2008 Aug; 102(4):434-9. PubMed ID: 18678301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.
    Paragh G; Balla P; Katona E; Seres I; Egerházi A; Degrell I
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):63-7. PubMed ID: 12111338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoproteins AI and B as therapeutic targets.
    Charlton-Menys V; Durrington P
    J Intern Med; 2006 May; 259(5):462-72. PubMed ID: 16629852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate.
    Taskinen MR; Sullivan DR; Ehnholm C; Whiting M; Zannino D; Simes RJ; Keech AC; Barter PJ;
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):950-5. PubMed ID: 19325138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.